CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- 8-A12B Other Registration of Securities
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale Chief Medical Officer sold 1,000 shares at $7.00 ($7,000)
- 4 Open-market sale Chief Commercial Officer sold 14,957 shares at $6.50 ($97,221)
- SC 13G Stake Amended Statement of Ownership
- 4 Grant or award Chief Commercial Officer acquired 150,899 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 303,846 shares (grant or award)
- 4 Grant or award General Counsel and Secretary acquired 150,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 153,846 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 153,688 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Commercial Officer sold 1,578 shares at $6.50 ($10,257)
Page 20 of 41 · 802 filings